会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Intracardiac lead having a compliant fixation device
    • 心内线具有顺应性固定装置
    • US5837007A
    • 1998-11-17
    • US824101
    • 1997-03-26
    • Peter A. AltmanM. Elizabeth BushDean F. Carson
    • Peter A. AltmanM. Elizabeth BushDean F. Carson
    • A61N1/05
    • A61N1/0573
    • Intracardiac lead for compliant fixation of a distal end of the lead to cardiac tissue. A fixation helix is disposed at the distal end of the lead. The fixation helix has a first end rigidly attached to the compliant fixation device and a second end that is sharpened to facilitate insertion of the fixation helix into cardiac tissue. The fixation helix can be designed to provide for either electrically active or inactive fixation. Once the lead is implanted in the cardiac tissue, the compliant fixation device, connecting the lead with the fixation helix, reduces the amount of lead movement that is transferred to the patient's tissue at the site of implantation of the fixation helix and reduces those forces from lead movement that could cause dislodgment of the fixation helix. The compliant fixation device thereby decreases the amount of irritation to the cardiac tissue, lessens the possibility of fibrous tissue growth around the area of the fixation helix, decreases the chance of dislodgment of the fixation helix, and reduces the possibility of perforation of the cardiac wall or tamponade of the pericardial sac.
    • 用于将铅的远端顺利地固定到心脏组织的心内线。 固定螺旋设置在引线的远端。 固定螺旋具有刚性地连接到顺应性固定装置的第一端和被锐化的便于将固定螺旋插入到心脏组织中的第二端。 固定螺旋可以设计成提供电活动或非活动固定。 一旦将铅植入心脏组织中,将引线与固定螺旋连接的顺应性固定装置减少了在植入固定螺旋部位时转移到患者组织的引线移动量,并将这些力从 导致运动可能导致固定螺旋的移动。 顺应性固定装置因此减少对心脏组织的刺激的量,减少了在固定螺旋区域周围的纤维组织生长的可能性,减少了固定螺旋的移动的可能性,并且降低了心脏壁穿孔的可能性 或心包囊的填塞。
    • 2. 发明授权
    • Intracardiac lead having a compliant fixation device
    • 心内线具有顺应性固定装置
    • US5658327A
    • 1997-08-19
    • US574801
    • 1995-12-19
    • Peter A. AltmanM. Elizabeth BushDean F. Carson
    • Peter A. AltmanM. Elizabeth BushDean F. Carson
    • A61N1/05
    • A61N1/0573
    • Intracardiac lead for compliant fixation of a distal end of the lead to cardiac tissue. A fixation helix is disposed at the distal end of the lead. The fixation helix has a first end rigidly attached to the compliant fixation device and a second end that is sharpened to facilitate insertion of the fixation helix into cardiac tissue. The fixation helix can be designed to provide for either electrically active or inactive fixation. Once the lead is implanted in the cardiac tissue, the compliant fixation device, connecting the lead with the fixation helix, reduces the amount of lead movement that is transferred to the patient's tissue at the site of implantation of the fixation helix and reduces those forces from lead movement that could cause dislodgment of the fixation helix. The compliant fixation device thereby decreases the amount of irritation to the cardiac tissue, lessens the possibility of fibrous tissue growth around the area of the fixation helix, decreases the chance of dislodgment of the fixation helix, and reduces the possibility of perforation of the cardiac wall or tamponade of the pericardial sac.
    • 用于将铅的远端顺利地固定到心脏组织的心内线。 固定螺旋设置在引线的远端。 固定螺旋具有刚性地连接到顺应性固定装置的第一端和被锐化的便于将固定螺旋插入到心脏组织中的第二端。 固定螺旋可以设计成提供电活动或非活动固定。 一旦将铅植入心脏组织中,将引线与固定螺旋连接的顺应性固定装置减少了在植入固定螺旋部位时转移到患者组织的引线移动量,并将这些力从 导致运动可能导致固定螺旋的移动。 顺应性固定装置因此减少对心脏组织的刺激的量,减少了在固定螺旋区域周围的纤维组织生长的可能性,减少了固定螺旋的移动的可能性,并且降低了心脏壁穿孔的可能性 或心包囊的填塞。
    • 10. 再颁专利
    • Implantable device for penetrating and delivering agents to cardiac tissue
    • 用于穿透和递送药物到心脏组织的可植入装置
    • USRE37463E1
    • 2001-12-11
    • US09146120
    • 1998-09-01
    • Peter A. Altman
    • Peter A. Altman
    • A61N105
    • A61N1/056A61F2/00A61N1/0573
    • An implantable devices for the effective elimination of an arrhythmogenic site from the myocardium is presented. By inserting small biocompatible conductors and/or insulators into the heart tissue at the arrhythmogenic site, it is possible to effectively eliminate a portion of the tissue from the electric field and current paths within the heart. The device would act as an alternative to the standard techniques for the removal of tissue from the effective contribution to the hearts electrical action which require the destruction of tissue via energy transfer (RF, microwave, cryogenic, etc.). This device is a significant improvement in the state of the art in that it does not require tissue necrosis. In one preferred embodiment the device is a non conductive helix that is permanently implanted into the heart wall around the arrhythmogenic site. In variations on the embodiment, the structure is wholly or partially conductive, the structure is used as an implantable substrate for anti arrhythmic, inflammatory, or angiogenic pharmacological agents, and the structure is deliverable by a catheter with a disengaging stylet. In other preferred embodiments that may incorporate the same variations, the device is a straight or curved stake, or a group of such stakes that are inserted simultaneously.
    • 提出了一种用于从心肌有效消除致心律失常部位的可植入装置。 通过将小的生物相容性导体和/或绝缘体插入致心律失常部位的心脏组织中,可以从心脏内的电场和电流路径有效地消除组织的一部分。 该装置将用作用于从对通过能量转移(RF,微波,低温等)破坏组织的对心脏电作用的有效贡献中去除组织的标准技术的替代。 该装置是现有技术的显着改进,因为其不需要组织坏死。在一个优选实施例中,该装置是永久地植入心律失常部位周围心脏壁的非导电螺旋。 在实施方案的变型中,结构全部或部分导电,该结构用作抗心律不齐,炎性或血管生成药理学的可植入底物,并且该结构可通过具有分离探针的导管递送。 在可以包含相同变化的其它优选实施例中,该装置是同时插入的直的或弯曲的桩或一组这样的桩。